Marshall Wace North America’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $9.88M | Buy |
107,846
+52,137
| +94% | +$4.78M | 0.04% | 355 |
|
|
2021
Q2 | $2.95M | Buy |
+55,709
| New | +$2.95M | 0.01% | 685 |
|
|
2021
Q1 | – | Sell |
-53,137
| Closed | -$1.48M | – | 1689 |
|
|
2020
Q4 | $1.48M | Buy |
53,137
+11,097
| +26% | +$308K | 0.01% | 835 |
|
|
2020
Q3 | $2.1M | Sell |
42,040
-17,203
| -29% | -$860K | 0.01% | 568 |
|
|
2020
Q2 | $2.74M | Buy |
59,243
+21,629
| +58% | +$1M | 0.02% | 501 |
|
|
2020
Q1 | $1.72M | Sell |
37,614
-65,928
| -64% | -$3.01M | 0.01% | 514 |
|
|
2019
Q4 | $5.81M | Buy |
+103,542
| New | +$5.81M | 0.03% | 365 |
|